Mr. Speaker, Roman is 21. He has suffered his whole life with cystic fibrosis: his lungs function at 40%. Physiotherapy and hospital visits fill up his days. Trikafta can save Roman's life, but it is not here in Canada. When I asked the minister why, she said she was waiting for Vertex to apply, but the real reason is the government has failed to fix PMPRB pricing regulations that keep innovative drugs like Trikafta out. It is being fast-tracked in other countries, so why is Canada lagging?
When will Roman have access to Trikafta?